{"id":1311,"date":"2018-09-28T16:48:38","date_gmt":"2018-09-28T14:48:38","guid":{"rendered":"http:\/\/lallianse.com\/site\/?p=1311"},"modified":"2018-09-28T16:48:38","modified_gmt":"2018-09-28T14:48:38","slug":"nanobiotix-to-present-positive-results-from-its-phase-ii-iii-clinical-trial-of-nbtxr3-in-patients-with-soft-tissue-sarcoma-sts-and-other-ongoing-phase-i-ii-trials-at-upcoming-esmo-and-astro-annual-c","status":"publish","type":"post","link":"https:\/\/lallianse.com\/site\/nanobiotix-to-present-positive-results-from-its-phase-ii-iii-clinical-trial-of-nbtxr3-in-patients-with-soft-tissue-sarcoma-sts-and-other-ongoing-phase-i-ii-trials-at-upcoming-esmo-and-astro-annual-c\/","title":{"rendered":"NANOBIOTIX TO PRESENT POSITIVE RESULTS FROM ITS PHASE II\/III CLINICAL TRIAL OF NBTXR3 IN PATIENTS WITH SOFT TISSUE SARCOMA (STS) AND OTHER ONGOING PHASE I\/II TRIALS AT UPCOMING ESMO AND ASTRO ANNUAL CONFERENCES"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00a0\u00bb1&Prime; _builder_version=\u00a0\u00bb3.7.1&Prime; custom_padding=\u00a0\u00bb0|0px|0|0px|false|false\u00a0\u00bb][et_pb_row custom_padding=\u00a0\u00bb0|0px|0|0px|false|false\u00a0\u00bb _builder_version=\u00a0\u00bb3.7.1&Prime;][et_pb_column type=\u00a0\u00bb4_4&Prime; _builder_version=\u00a0\u00bb3.0.47&Prime; parallax=\u00a0\u00bboff\u00a0\u00bb parallax_method=\u00a0\u00bbon\u00a0\u00bb][et_pb_text _builder_version=\u00a0\u00bb3.7.1&Prime; text_font=\u00a0\u00bb||||||||\u00a0\u00bb text_orientation=\u00a0\u00bbjustified\u00a0\u00bb custom_margin=\u00a0\u00bb||10px|\u00a0\u00bb]<\/p>\n<p>Nanobiotix\u00a0announced today that detailed results of its phase II\/III clinical trial of NBTXR3 in patients with soft tissue\u00a0sarcoma (STS) will be presented by Dr. Sylvie Bonvalot, MD, PhD at the ESMO 2018 Congress in Munich<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=\u00a0\u00bbhttp:\/\/www.nanobiotix.com\/download\/news_en\/2018\/PR_Nanobiotix_ESMO-ASTRO_20180926_VF.pdf\u00a0\u00bb url_new_window=\u00a0\u00bbon\u00a0\u00bb button_text=\u00a0\u00bbRead the press release\u00a0\u00bb button_alignment=\u00a0\u00bbright\u00a0\u00bb _builder_version=\u00a0\u00bb3.7.1&Prime; custom_button=\u00a0\u00bbon\u00a0\u00bb button_text_size=\u00a0\u00bb16px\u00a0\u00bb button_font=\u00a0\u00bb||||||||\u00a0\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nanobiotix, a  late  clinical stage  nanomedicine  company  pioneering new approaches in the treatment of cancer, announced  today positive topline  results  of  the  Phase II\/III act.in.sarc trial  evaluating NBTXR3 in  Soft Tissue Sarcoma.<\/p>\n","protected":false},"author":1,"featured_media":585,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":""},"categories":[8],"tags":[],"jetpack_featured_media_url":"https:\/\/lallianse.com\/site\/wp-content\/uploads\/2018\/07\/nanobiotix.jpg","_links":{"self":[{"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/posts\/1311"}],"collection":[{"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/comments?post=1311"}],"version-history":[{"count":2,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/posts\/1311\/revisions"}],"predecessor-version":[{"id":1317,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/posts\/1311\/revisions\/1317"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/media\/585"}],"wp:attachment":[{"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/media?parent=1311"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/categories?post=1311"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lallianse.com\/site\/wp-json\/wp\/v2\/tags?post=1311"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}